{
  "docId": "019dd923-622c-750b-8b99-bca3fd68622d",
  "docSlug": "4c8fe6013c68",
  "documentTitle": "iRhythm Technologies, Inc. (IRTC)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 37,
  "pageCount": 101,
  "prevPage": 36,
  "nextPage": 38,
  "slideType": "competitive_analysis",
  "function": "expose_gap",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "The slide uses a mix of news snippets and clinical study results to demonstrate that competitors have already achieved FDA clearance and multi-sensor capabilities.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "screenshot",
    "icon_grid"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-bca3fd68622d/37",
  "deckHref": "/decks/019dd923-622c-750b-8b99-bca3fd68622d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-bca3fd68622d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-bca3fd68622d#slide-37",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.48,
        "x": 0.02,
        "y": 0.81
      },
      "kind": "callout",
      "text": "As we note later, the Apple Watch sleep apnea monitor received FDA approval in September 2024.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1dada44d-4482-4fd2-b41f-165f9144bcc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.96,
        "x": 0.02,
        "y": 0.27
      },
      "kind": "callout",
      "text": "New Multi-Sensor Product Targeting Cardiac and Sleep Health Supported by Research",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e864e134-e0e0-406c-8dd6-834bb560c56e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.52,
        "y": 0.62
      },
      "kind": "list",
      "text": "ECG rhythm, Heart rate, Heart rate variability, RR-interval, Respiratory rate, Skin temperature, Step count, Posture, 3-Axis accelerometer",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74d1fe6b-79c3-4a9f-ab0c-a10b6263b657",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.96,
        "x": 0.02,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "iRhythm made a minority investment in BioIntelliSense in 2024 to expand its portfolio of sensor technologies in order to address additional indications, sleep apnea in particular. Despite touting this application as a potential long-term growth opportunity, other companies seem to have already beaten the Company to the punch. In addition, we note that one inherent advantage of smartphone-paired devices is the ease with which they can add additional apps to target new indications.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46e0724d-3129-4c90-bc31-aec2d9ea58e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.96,
        "x": 0.02,
        "y": 0.32
      },
      "kind": "paragraph",
      "text": "Huxley Medical Announces FDA Clearance for Cellular-Enabled SANSA Home Sleep Apnea Test. SANSA's initial FDA clearance in 2024 validated accuracy against gold-standard polysomnography in a 340-patient clinical trial conducted at seven institutions.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bd3039e-e70a-475f-ace0-2db9103a1f3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.48,
        "x": 0.02,
        "y": 0.43
      },
      "kind": "paragraph",
      "text": "Multidiagnostic chest-worn patch to detect obstructive sleep apnea and cardiac arrhythmias. Results: SANSA's sensitivity and specificity to detect obstructive sleep apnea ranged from 91-97% and 78-97%.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bbff7f41-cf01-4533-bd4e-ddea1d2fff97",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "SANSA's initial FDA clearance in 2024 validated accuracy against gold-standard polysomnography in a 340-patient clinical trial conducted at seven institutions. — Huxley Medical",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64d2-7657-bbed-6c053103ca8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.02,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Source: Huxley Medical press release, Journal of Clinical Sleep Medicine, Vivalink",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9ecb3a3-c052-4946-8b10-64fa71353e8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.65,
        "x": 0.31,
        "y": 0.03
      },
      "kind": "title",
      "text": "There Are Already Numerous Multi-Sensor Solutions On The Market",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2cdbd1a6-e23e-40db-87cc-cb1085d86ee6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 40,
      "from": 25,
      "beatId": "0a38a245-fa4d-49e4-b7bb-ca7320e46cc1",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Thesis Headline",
      "beatSlug": null,
      "evidence": "The document presents Spruce Point Capital Management's thesis and key messages.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}